In the 1980s and early 1990s, America\'s system of workers\' compensation insurance was in trouble. Costs grew rapidly because of escalating medical costs, the increased involvement of attorneys in claims disputes, growing residual markets, and the expansion of compensable injuries....

The high cost of R&D makes pharmaceuticals vulnerable to aggressive price regulation. Yet even stringent price regulatory systems have failed to control total drug expenditures....